Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 study evaluating the efficacy and safety of once-daily instillation of a combination glaucoma therapy in adults with open-angle gl…
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients [Phase 2]
Phase II safety and efficacy study evaluating a glaucoma therapy in open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial of a glaucoma therapy for open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial investigating a glaucoma therapy for open-angle glaucoma or ocular hypertension has completed.
-
FDA approval · 2012-02-10FDA Approved: TAFLUPROST OPHTHALMIC — Original Application (Prasco Laboratories)
FDA approves tafluprost ophthalmic solution under an original application for Prasco Laboratories.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-02-10Clinical Trial Update: Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% [Phase 3]
A Phase 3 study comparing TRAVATAN to Travoprost Ophthalmic Solution (0.004%) for open-angle glaucoma and ocular hypertension has been withd…
-
FDA approval · 2012-02-01FDA Approved: COSOPT PF — Original Application (Thea Pharma Inc.)
FDA approved Cosopt PF (dorzolamide hydrochloride and timolol maleate) under an original application from Thea Pharma Inc. for reducing elev…
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: Safety and Efficacy of a Drug Delivery System in Glaucoma [Phase 2]
Phase 2 trial results for a glaucoma drug delivery system showed safety and preliminary efficacy in open-angle glaucoma and ocular hypertens…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension [NA]
Clinical trial update on the safety and efficacy of bimatoprost timolol ophthalmic solution for open-angle glaucoma or ocular hypertension; …
-
CLINICAL_TRIALS withdrawal · 2012-01-18Clinical Trial Update: Safety and Efficacy Study of DuoTrav APS Versus DuoTrav [Phase 3]
A Phase 3 safety and efficacy trial comparing DuoTrav APS to DuoTrav was withdrawn, involving open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2012-01-16Clinical Trial Update: Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1]
Phase 1 safety and pharmacodynamics study of AGN-207281 ophthalmic solution compared with timolol ophthalmic solution or placebo in ocular h…
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan® [Phase 4]
Phase 4 trial comparing safety and efficacy of Combigan and Lumigan versus Lumigan alone in glaucoma or ocular hypertension; results posted …
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
This clinical trial update reports on the safety and efficacy of bimatoprost, latanoprost, and travoprost in patients with elevated intraocu…
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects [Phase 4]
Phase 4 trial comparing the efficacy and safety of Combigan versus Timolol added to Xalatan in glaucoma or ocular hypertension; results post…
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: 24-hour IOP-lowering Effect of Brimonidine 0.1% [Phase 4]
A Phase 4 trial assessing the 24-hour intraocular pressure-lowering effect of brimonidine 0.1% in open-angle glaucoma and ocular hypertensio…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 study of DE-104 ophthalmic solution for open-angle glaucoma or ocular hypertension has completed, reporting safety and efficacy resu…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
The safety and efficacy study of DE-104 ophthalmic solution for open-angle glaucoma or ocular hypertension has completed Phase 1 and Phase 2…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues [Phase 4]
Phase 4 trial evaluating hyperemia with ocular prostaglandin analogues in open angle glaucoma and ocular hypertension; results posted in 201…
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing safety and efficacy of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension has completed…
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 trial evaluating safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension has completed with results post…
-
FDA approval · 2011-09-30FDA Approved: TIMOPTIC IN OCUDOSE — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for TIMOPTIC IN OCUDOSE (timolol maleate) submitted by Bausch & Lomb Incorporated.
-
FDA approval · 2011-09-30FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb, reflecting an approved update to the product's…
-
CLINICAL_TRIALS trial_result · 2011-09-26Clinical Trial Update: A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin
A retrospective evaluation of intraocular pressure spikes associated with Loteprednol and Loteprednol/tobramycin in ocular hypertension pati…
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects [Phase 4]
Phase 4 clinical trial evaluating the fixed combination brimonidine tartrate 0.2%/timolol maleate 0.5% versus latanoprost 0.005% in subjects…
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) [Phase 3]
The Phase 3 study MK2452-001 evaluating preservative-free tafluprost for open-angle glaucoma and ocular hypertension has completed, with res…